2025-02-01 2026-01-31 false No description of principal activity Acting Office - Tax and Accounts 1.0 12418897 bus:FullAccounts 2025-02-01 2026-01-31 12418897 bus:Micro-entities 2025-02-01 2026-01-31 12418897 bus:AuditExempt-NoAccountantsReport 2025-02-01 2026-01-31 12418897 bus:SmallCompaniesRegimeForAccounts 2025-02-01 2026-01-31 12418897 bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 12418897 2025-02-01 2026-01-31 12418897 2026-01-31 12418897 bus:RegisteredOffice 2025-02-01 2026-01-31 12418897 core:WithinOneYear 2026-01-31 12418897 core:AfterOneYear 2026-01-31 12418897 2024-02-01 12418897 bus:Director1 2025-02-01 2026-01-31 12418897 bus:Director1 2026-01-31 12418897 bus:Director1 2024-02-01 2025-01-31 12418897 bus:CompanySecretary1 2025-02-01 2026-01-31 12418897 bus:LeadAgentIfApplicable 2025-02-01 2026-01-31 12418897 2024-02-01 2025-01-31 12418897 2025-01-31 12418897 core:WithinOneYear 2025-01-31 12418897 core:AfterOneYear 2025-01-31 12418897 bus:EntityAccountantsOrAuditors 2024-02-01 2025-01-31 12418897 core:CostValuation core:Non-currentFinancialInstruments 2026-01-31 12418897 core:CostValuation core:Non-currentFinancialInstruments 2025-01-31 12418897 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-01-31 12418897 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 12418897 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 12418897 core:ShareProfitOrLossIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 12418897 core:ProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2026-01-31 12418897 core:ImpairmentReversalProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2026-01-31 12418897 core:ForeignExchangeDifferencesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 12418897 core:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 12418897 core:TransfersBetweenInvestmentClassesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 12418897 core:Non-currentFinancialInstruments 2026-01-31 12418897 core:Non-currentFinancialInstruments 2025-01-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 12418897
England and Wales

 

 

 


Unaudited Financial Statements

for the year ended 31 January 2026

for

GLOBAL BIOCLEAN LTD

 
 
 
£
2026
£
   
£
2025
£
Current assets 4,318  7,734 
Creditors: amount falling due within one year (5,962) (5,764)
Net current assets/(liabilities) (1,644) 1,970 
Total assets less current liabilities (1,644) 1,970 
Creditors: amount falling due after more than one year (21,256)
Net assets/(liabilities) (22,900) 1,970 
 
Capital and reserves (22,900) 1,970 
 



Notes to the Accounts
Statutory Information
Global Bioclean Ltd is a private limited company, limited by shares, domiciled in England and Wales, registration number 12418897, registration address 52 Aldgate Ketton, Stamford, PE9 3TD, England.

The presentation currency is £ sterling.
1.

Accounting Policies

Basis of accounting
The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016).
2.

Average number of employees

Average number of employees during the year were 2 (2025: 2).

Director's Responsibilities:
  1. For the year ended 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
  2. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions.

Signed on behalf of the board of directors:


---------------------------------------------
John Martin Thomas Charlesworth
Director

Date approved: 01 September 2026
1